Erythropoietin and iron for anemia in HIV-infected patients undergoing maintenance hemodialysis in China: A cross-sectional study
BMC Nephrology — Peng L, He Y, Zhang J, et al. | February 10, 2022
Anemia is a common complication of chronic kidney disease (CKD) as well as HIV infection. Herein researchers investigated the difference between HIV-hemodialysis (HD) patients and HD patients in terms of hemoglobin (Hgb) and treatments like erythropoietin and iron.
In this cross-sectional study, researchers assessed data of 34 HIV-infected HD patients and 35 non-HIV-infected HD patients.
HIV-HD and HD groups had Hgb of 105.70 (95.93–112.08) g/L and 112.00 (93.00–126.00) g/L respectively.
HIV-HD patients may require a higher erythropoietin dosage and a higher probability of iron preparations to maintain Hgb compared with HD patients.
Read the full article on BMC Nephrology